|
|
Biotech::Trekker Trekking Through the World of Biotech {created 11 October 2002} |
|
|
(old) Dr. Von Hoff Featured On Page A1
I posted the following to my AzCentral.com blog on 19 August 2010.
My AzCentral.com blog posting -- Keep bioscience news on A1 -- generated zero comments. [29 August 2010, top] |
|
6 October 2010 is Stem Cell Awareness Day
I agree with Arnold Schwarzenegger...
"California is poised to lead not only this country, but all
countries on stem cell research. We cannot fall behind the
nations who are making this life-saving science a priority"
-- Arnold Schwarzenegger, California Governer
StemCellDay.com::Stem Cell Awareness Day on 6 October 2010
[29 August 2010, top] |
|
Northern California is a Biotech Leader
The United States of American needs Northern California to be a strong biotechnology/bioscience hub.
"Arguably, you will find no other greater concentration of
biotechnology than in Northern California, the birthplace
of biotechnology. We stand arm-in-arm with San Diego and
Boston/Cambridge."
Xconomy.com::How Bay Area Biotech Stacks Up With the Rest of the World [23 August 2010, top] |
|
SPIEGEL Interview with Craig Venter
Craig Venter is an American biologist/entrepreneur. He played a key role in the sequencing of the human genome and the creation of the first cell with a synthetic genome.
"Over the next 20 years, synthetic genomics is going to become
the standard for making anything." -- Venter in 2007
SPIEGEL interviewed Craig Venter in 2010.
"SPIEGEL: So the Human Genome Project has had very
little medical benefits so far?"
"Venter: Close to zero to put it precisely."
SPIEGEL.de::Interview with Craig Venter [21 August 2010, top] |
|
Eliminate Pain Sans Trip
Fururity.org posted: "The human body manufactures several cell signals that mimic the actions of marijuana-derived chemicals."
"[...] give patients the same medicinal benefits as marijuana
without its mind-altering properties."
If somebody is grossly ill, then should get pain relief with the option of taking a "trip." Futurity.org::Pain relief (sans trip) via body's 'marijuana' [17 August 2010, top] |
|
Geron Moves Forward With Embryonic Stem Cell Study
Kudos to Menlo Park, CA-based Geron Corporation. (NasdaqGM: GERN; $5.81 at 9:56am EDT)
"When we look back in 25 years, putting the first embryonic
stem cells into humans will prove as momentous as man's
first step on the moon." -- Chris Mason, professor of
regenerative medicine at University College London
Only time will tell of professor Mason is right or wrong. NewScientist.com::Green light for first embryonic stem cell treatment [03 August 2010, top] |
|
1000 Genomes Project is Making Progress
About The "1000 Genomes Project"
"Recent improvements in sequencing technology ('next-gen'
sequencing platforms) have sharply reduced the cost of
sequencing. The 1000 Genomes Project is the first project
to sequence the genomes of a large number of people, to
provide a comprehensive resource on human genetic variation."
We are living in the Age of Genomics. BCM is the Baylor College of Medicine. BCM.edu::1000 Genomes project releases pilot data [08 July 2010, top] |
|
Keep an Eye On Arterioctye, Inc.
Keep an eye on Arteriocyte.
"Arteriocyte, a clinical stage Biotechnology company with
offices in Cleveland, Ohio and Hopkinton, Massachusetts,
is developing proprietary stem cell and tissue engineering
based therapies."
DARPA knows about Arteriocyte.
"We're basically mimicking bone marrow in a lab environment,"
company CEO Don Brown tells Danger Room. "Our model works, but
we need to extrapolate our production abilities to make scale."
Wired.com::DARPA's Genetically Engineered Blood Starts Pumping [08 July 2010, top] |
|
ISSCR--What to Ask a Stem Cell Clinic
The International Society for Stem Cell Research is considered about stem cell fraud (i.e. mis- and dis-information). They have created a website that includes a webpage about "What to Ask a Stem Cell Clinic." CloserLookAtStemCells.orgs::Considering stem cell treatment? [02 July 2010, top] |
|
LabSpaces.net: Turning Back the Cellular Clock
It might only be 1% today, but 1% of something greater than zero is greater than zero.
"It's a new technology that uses molecular therapy to coax adult
cells to revert to an embryonic stem cell-like state, allowing
scientists to later re-differentiate these cells into specific
types with the potential to treat heart attacks or diseases such
as Parkinson's. But at this point in the technology's development,
only one percent of cells are successfully being reprogrammed."
Kudos to Tel Aviv University and Harvard University. LabSpaces.net::Turning back the cellular clock [29 June 2010, top] |
|
ASU Biodesign Institute BiodesignExtra Newsletter
I've subscribed to the BiodesignExtra online newsletter published by the ASU Biodesign Institutute. [09 June 2010, top] |
|
Things Looking Up At Aastrom Biosciences?
Two items. First, Ann Arbor-based Aastrom Biosciences announced it has formed a scientific advisory board in order to gain "guidance and expertise in stem cell biology and cardiovascular disease." Second, an interview with Aastrom's CEO has been posted to the web.
"The biggest challenge for Aastrom is that a lot of people
in the life sciences industry think stem cell therapies
are many years away from being commercialized. At Aastrom,
we don't think we're that far away." -- Tim Mayleben, CEO
MedCityNews.com::Q&A: Aastrom Biosciences' CEO Tim Mayleben [14 April 2010, top] |
|
Learning About Bio By Following TGen On Twitter
TGen tweeted the following between 23 March 2010 and 12 April 2010.
[12 April 2010, top] |
|
AzBiotech.net Domain Name Renewed
I have renewed the AzBiotech.net domain name for another year. On 3 April 2010, AzBiotech.net turned seven years of age. [10 April 2010, top] |
|
Political Bullfoo To the N-th Degree
I received the following tweet from @HealthReformNow on 3 March 2010. Fact of the Day: W/O #hcr by 2019, employment-based spending on health care at large employers will be 166% higher My burning question: How are politicians factoring in advances in HPC-based 21st century Informatics, biotechnology, molecular nanotechnology, and robotics? I know the answer: They aren't! If the tweet was a "fact of the day," then that is political bullfoo the nth-degree. [03 March 2010, top] |
|
Making Old Stem Cells Act Young Again
I have to keep learning about stem cells.
"A team of Howard Hughes Medical Institute (HHMI) researchers
has found that in old mice, a several-week exposure to the
blood of young mice causes their bone marrow stem cells to
act 'young' again."
HHMI.org::Making Old Stem Cells Act Young Again [01 February 2010, top] |
|
Keeping an Eye on Complete Genomics, Inc.
I need to keep an eye on Complete Genomics. "We are a data company." Cliff Reid, CEO Complete Genomics SingularityHub.com::Exclusive: Complete Genomics To Sequence 1 Million Genomes -- Interview With CEO Just like Google, Complete Genomics, Inc. is located in Mountain View, California. Complete Genomics scientific advisory board on 27 January 2010.
Dr. Mark Chee, CEO/CSO of Prognosys Biosciences, Inc.
Dr. George Church, Professor of Genetics at Harvard Medical
School and Director of the Center for Computational Genetics
Dr. Leroy Hood, President of the Institute for Systems Biology
Dr. Douglas A. Lauffenburger, Uncas & Helen Whitaker Professor
of Bioengineering and Director of the Biological Engineering
Division at MIT, and also holds appointments in the Department
of Biology and the Department of Chemical Engineering
CompleteGenomics.com::Powering large-scale human genome studies [27 January 2010, top] |
|
Using Bioinformatics To Find Partners
The Match.com's and eHarmony's of the 21st century? WashingtonPost.com::Using genetic information to match singles with potential partners [24 January 2010, top] |
National Geographic Reports On Bionics
@nanofoo received the following tweet
from @singularityu on 2010.01.19.
National Geographic: "Merging Man And Machine - A Better Life With Bionics" http://bit.ly/8sWl22 [23 January 2010, top] |
BIOFAB: Open-Source Genetic Parts Production Facility
@MathBabbler received the following tweet from
@BerkeleyLab on 2010.01.21. Note: This tweet
was a retweeted by @chr1sa.
Beyond Legos: Berkeley Lab helps launch first open-source genetic parts production facility http://bit.ly/5zJxmI Berkeley.edu reported that they are establishing BIOFAB.
"International Open Facility Advancing Biotechnology (BIOFAB),
aims to produce thousands of free, standardized DNA parts to
shorten the development time and lower the cost of synthetic
biology for academic or biotech laboratories."
Berkeley.edu::NSF grant to launch world's first open-source genetic parts production facility [21 January 2010, top] |
|
The Next Decade of Molecular Medicine
Question: "Can molecular medicine survive its teenage years, and reach its potential this decade?" My initial response was: "I'm assuming it would; therefore, I hope so." But... the keyword in my reponse is "hope." In other words, I haven't a clue.
"The key is to shift from diagnosing patients when they already
have symptoms to detecting disease much earlier, before symptoms
appear. This is the potential that molecular medicine brings to
personalized healthcare delivery. Personalized healthcare will
be predictive and preventive, probing an individual's unique
biology to assess disease probability and then designing
appropriate treatments, even before symptoms."
--Matthew O'Donnell, Dean of the University of
Washington's College of Engineering
I'm still clueless after reading O'Donnell's article at Xconomy.com, but I'm still hoping that molecular medicine will make significant advances over the span of the next decade. Xconomy.com::Can Molecular Medicine Survive Its Teenage Years, and Reach its Potential This Decade? [15 January 2010, top] |
|
Illuminia Announces the HiSeq 2000
I tweeted the following on 2010.01.13. Illumina (nasdaq: ILMN) HiSeq 2000 can sequence a human genome for less than $10K. (pr) http://ow.ly/VZd9 We're living in the Genomics Age and the cost of genome sequencing keeps getting cheaper and cheaper. [13 January 2010, top] |
|
Induced Pluripotent Stem Cells
Powerful, but scary bioscience. "induced pluripotent stem cells" #IPScells ScientificAmerican.com http://ow.ly/S0lK [03 January 2010, top] |
|
About the Biotech Trekker
The Biotech Trekker was started during October of 2002 and it enters 2010 with 368 postings. There are going to be a lot of postings about smart drugs, stem cells and cloning over the span of this year. Biotech Trekker Archives: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003-02 [01 January 2010, top] |
|
Creator: Gerald Thurman
[gdt@deru.com] Created: 11 October 2002 Last Modified: Sunday, 29-Aug-2010 07:12:15 MST |